Search results for: 'biological solutions'

20 Nov 2017  |  North America  |  Market Research

Global Biologics Market—Companies-to-Action

Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

Infographics

×

This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

11 Jan 2021  |  North America  |  Market Research

Increasing Demand for Value-based Care and Acute Shortage of ICU Staff to Drive Growth of the US & EU-5 Virtual Critical Care Solutions Market, 2025

Future Growth Potential to Be Accelerated by Opportunities in Affordable, Easy-to-Deploy, and Scalable Solutions

Infographics

×

Coronavirus (COVID-19) has fuelled a demand for solutions that can help cater to large patient populations remotely. Further, the shortage of intensivists, as estimated by the COMPACCS trial, is expected to increase from 22% in 2020 to 35% by 2030. These, as well as changing reimbursement policies, are some of the key trends that will define the fu...

19 Sep 2018  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

Infographics

×

Key Issues Addressed

The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 a...

15 May 2023  |  North America  |  Market Research

Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast

Opportunities in Type 2 Diabetic and Non diabetic Patients Treatment Boost Future Growth Potential

Infographics

×

The rising prevalence of diabetes entails a greater need for treatment and monitoring. In this context, multiple growth opportunities arise in the continuous glucose monitoring (CGM) solutions market. CGM devices have been extensively used for Type 1 diabetes patients. With further technological development and clinical studies, CGM’s applications ...

The pandemic years left different learnings in terms of mental and behavioral health. The isolation addressed the migration of patients with different needs and conditions from on-site treatments to digital platforms and solutions, highlighting benefits and challenges for providers and users. The main pivotal change is a new, holistic mental and be...

Healthcare providers and payers are operating under the pressure of rising healthcare costs, demand for better health outcomes, and the need to improve the digital patient experience. All major healthcare stakeholders acknowledge the need to invest in digital infrastructure, and provider-payer collaboration capabilities to facilitate cross-cont...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...